One of the most well studied radiotracers for HER2 imaging is 89Zr-labeled trastuzumab, which allowed visualization and quantification of uptake in HER2-positive lesions for patients with metastatic BCa and other cancers in several clinical trials [7–10]. The gene discussed is ERBB2; the disease is cancer.